1-4 of 4
Amy E Boles
Close
Sort by
Journal Articles

Therapeutic Potential and Role of CD38 in Cutaneous T-Cell Lymphoma Pathogenesis

Colleen Isabelle, Kathleen McConnell, Amy E Boles, Jonathan E Brammer, Robyn Berge, Carla Portocarrero, Nitin Chakravarti, Pierluigi Porcu, Neda Nikbakht, Anjali Mishra
Journal: Blood
Blood (2022) 140 (Supplement 1): 9216–9218.
https://doi.org/10.1182/blood-2022-170550
Published: 2022
Journal Articles

Efficient Targeting of CD38 in Mature T-Cell Neoplasms with Daratumumab and Allogeneic NK Cells

William T. Johnson, Colleen Isabelle, Ashley N Vogel, Jonathan E Brammer, Amy E Boles, Kathleen McConnell, Robyn Berge, Liam Nisenfeld, Guldeep Uppal, Jerald Gong, Nitin Chakravarti, Pierluigi Porcu, Anjali Mishra
Journal: Blood
Blood (2021) 138 (Supplement 1): 2408.
https://doi.org/10.1182/blood-2021-154234
Published: 2021
Journal Articles

Role of Mir-29b in T-Cell Development and in Cutaneous T-Cell Lymphoma Pathogenesis

Anthony Mansour, MD, David Clever, Colleen Isabelle, Amy E Boles, BS, Kathleen McConnell, Zhiyao Li, Logan A Chrislip, Michael A. Caligiuri, MD, Anjali Mishra, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
https://doi.org/10.1182/blood-2020-142145
Published: 2020
Journal Articles

Reversible DNA Hypermethylation of the Interleukin-15 (IL-15) Promoter Induces IL-15 Expression, Drives the Pathogenesis of T-Cell Large Granular Lymphocytic Leukemia and Provides a Potential Therapeutic Approach Using 5-Azacitidine

Jonathan E Brammer, MD, Amy E Boles, BS, Anthony Mansour, MD, Aharon G. Freud, MD PhD, Monique Mathé-Allainmat, Agnès Quéméner, Erwan Mortier, Pierluigi Porcu, MD, Anjali Mishra, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3776.
https://doi.org/10.1182/blood-2019-131174
Published: 2019